Skip to main content
Equibles
BCLI logo

BCLI · Brainstorm Cell Therapeutics Inc. · Webcasts, Transcripts & Audio

Track BCLI — free

Use BCLI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BCLI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.84 -0.33 (-28.21%) At close · Jul 18
Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Such conditions raise substantial doubts about the Company’s ability to continue as a going concern. Management’s plan includes raising funds from outside potential investors, however, as mentioned above, there is no assurance such funding will be available to the Company or that it will be obtained on terms favorable to the Company or will provide the Company with sufficient funds to meet its objectives.”
View the 10-Q filed Aug 14, 2026
Market Cap
$10.81M
Shares
11.03M
Volume · Jul 18 819.7K Avg daily vol (3M) 1.39M

Brainstorm Cell Therapeutics Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Brainstorm Cell Therapeutics Inc. (BCLI), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →
Earnings call
FY25 · Q3
2025-11-14
Brainstorm Cell Therapeutics Inc. (BCLI) Q3 2025 Earnings Call
Diluted EPS
$-0.19
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-14
Brainstorm Cell Therapeutics Inc. (BCLI) Q2 2025 Earnings Call Transcript
Balanced tone Phase IIIb ENDURANCE trial preparations Patient advocacy and right to try Citizens petition for NurOwn reevaluation
Diluted EPS
$-0.34
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-19
Brainstorm Cell Therapeutics Inc. (BCLI) Q1 2025 Earnings Call Transcript
Positive tone FDA clearance and SPA for Phase 3b ENDURANCE trial UNC13A biomarker and genetic stratification Trial design and ALSFRS-R endpoint
Diluted EPS
$-0.45
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-31
Brainstorm Cell Therapeutics Inc. (BCLI) Q4 2024 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-14
Brainstorm Cell Therapeutics Inc. (BCLI) Q3 2024 Earnings Call
Diluted EPS
$-0.51
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-14
Brainstorm Cell Therapeutics Inc. (BCLI) Q2 2024 Earnings Call Transcript
Positive tone NurOwn Therapeutic Platform & ALS Unmet Need Phase 3b Trial Progress & Timeline Patient Advocacy & Community Support
Diluted EPS
$-0.60
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-04-01
Brainstorm Cell Therapeutics Inc. (BCLI) Q1 2024 Earnings Call
Diluted EPS
$-0.75
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q3
2023-11-14
Brainstorm Cell Therapeutics Inc. (BCLI) Q3 2023 Earnings Call Transcript
Diluted EPS
$-0.45
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-14
Brainstorm Cell Therapeutics Inc. (BCLI) Q2 2023 Earnings Call Transcript
Diluted EPS
$-1.95
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-15
Brainstorm Cell Therapeutics Inc. (BCLI) Q1 2023 Earnings Call Transcript
Diluted EPS
$-2.10
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-30
Brainstorm Cell Therapeutics Inc. (BCLI) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-14
Brainstorm Cell Therapeutics Inc. (BCLI) Q3 2022 Earnings Call Transcript
Diluted EPS
$-2.85
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-15
Brainstorm Cell Therapeutics Inc. (BCLI) Q2 2022 Earnings Call Transcript
Diluted EPS
$-2.85
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-16
Brainstorm Cell Therapeutics Inc. (BCLI) Q1 2022 Earnings Call Transcript
Diluted EPS
$-2.25
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-28
Brainstorm Cell Therapeutics Inc. (BCLI) Q4 2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q2
2021-08-05
Brainstorm Cell Therapeutics Inc. (BCLI) Q2 2021 Earnings Call
Diluted EPS
$-2.55
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-04-26
Brainstorm Cell Therapeutics Inc. (BCLI) Q1 2021 Earnings Call
Diluted EPS
$-2.85
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-04
Brainstorm Cell Therapeutics Inc. (BCLI) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-10-15
Brainstorm Cell Therapeutics Inc. (BCLI) Q3 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-06-30
Brainstorm Cell Therapeutics Inc. (BCLI) Q2 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-03-31
Brainstorm Cell Therapeutics Inc. (BCLI) Q1 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–21 of 21 webcasts
Key facts CIK 1137883 CUSIP 10501E300 Visit website Investor relations